Clinical Trials
37 trialsROSE
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
PRISME
Ipsen
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Tanta University
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
PRONOSTIM
Assistance Publique - Hôpitaux de Paris
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
LymphoVie 2
Centre Hospitalier Universitaire Dijon
Radium-223 Dichloride Long-term Follow-up Program
Bayer
Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania
University Hospital, Basel, Switzerland
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
Sixth Affiliated Hospital, Sun Yat-sen University
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
Centre Hospitalier Universitaire de Saint Etienne
IRMYG
Centre Hospitalier Universitaire de Saint Etienne
CASSIOPE
Ipsen
MESOIMMUNE
Centre Hospitalier Intercommunal Creteil
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
doc.ai inc
Optional Sub-study to Intraoperative Imaging With ICG Registry
Abramson Cancer Center at Penn Medicine
OPERA
Ipsen
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Ipsen
COATS+
University Hospital, Limoges
RECOSY
Ipsen
Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females
GlaxoSmithKline
LUMINIST
AstraZeneca
OSCA
AstraZeneca
Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
GlaxoSmithKline
head neck-mel
CHU de Reims
RITUX-LEUKEMIA
CHU de Reims
PGRx
GlaxoSmithKline
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
GlaxoSmithKline
Lynne Cohen Consortium Project: Multi-Center Database/Registry
M.D. Anderson Cancer Center
LuCaBIS
GlaxoSmithKline
Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK
GlaxoSmithKline
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
GlaxoSmithKline
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
GlaxoSmithKline
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
GlaxoSmithKline
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
GlaxoSmithKline